Daratumumab resistance is frequent in advanced ‐stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis

European Journal of Haematology, EarlyView.

Source: European Journal of Haematology - March 25, 2018 Category: Hematology Source Type: research